Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma
-
Ali Mosayebian
,
Zohreh Koohini
,
Hadi Hossein-Nataj
,
Saeid Abediankenari
,
Siavash Abedi
,
Hossein Asgarian-Omran
Abstract
Asthma is a chronic disorder of the airways characterized by reversible airflow obstruction, inflammation and bronchial hyperresponsiveness. Different immune cells and molecules have been attributed to involve in pathogenesis of asthma. In the current case-control study, the expression of T cell Ig and mucin domain-containing molecule-3 (Tim-3) and programmed death-1 (PD-1) was studied on CD4+ T cells of patients with asthma and normal controls. The frequency of Tim-3+/PD-1+/CD4+ T cells was determined by a three color flow cytometry method in 37 patients with asthma and 32 healthy controls. To evaluate the Th1/Th2 ratio, peripheral blood mononuclear cells were isolated from all samples and stimulated with phorbol 12- myristate 13- acetate ( PMA)/ionomycin for 18 h. IFN-γ) and Interleukin-4 (IL-4) were measured in culture supernatants by-(ELISA). Serum total immunoglobulin E (IgE) was also measured in all samples. Significant increase in percentage and absolute count of Tim-3+/PD-1+/CD4+, Tim-3+/CD4+ and PD-1+/CD4+ T cells was found in asthmatic patients compared to healthy controls (p=0.02 and p=0.003, respectively). The IFN-γ/IL-4 ratio (Th1/Th2 ratio) was significantly higher in healthy controls than that of asthmatic patients (p=0.029). Our data regarding the increased expression of PD-1 and Tim-3 on CD4+ T cells of patients with asthma suggest the potential roles of these immune checkpoint receptors in immune dys-regulation of asthma.
References
1. Umetsu DT, DeKruyff RH. Current perspectives: focused commentary: key cells in asthma. The Journal of allergy and clinical immunology. 2010;125(5):975.
2. Shi Y, Shi G, Wan H, Jiang L, Ai X, Zhu H, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chinese medical journal. 2011;124(13):1951-6.
3. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. The Lancet. 2008;372(9643):1107-19.
4. Bice JB, Leechawengwongs E, Montanaro A. Biologic targeted therapy in allergic asthma. Annals of Allergy, Asthma & Immunology. 2014;112(2):108-15.
5. Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation. Immunity. 2016;44(5):989-1004.
6. Taghiloo S, Allahmoradi E, Tehrani M, Hossein-Nataj H, Shekarriz R, Janbabaei G, et al. Frequency and functional characterization of Exhausted CD8+ T-cells in chronic lymphocytic leukemia. European journal of haematology. 2017. Epub 2017/03/18.
7. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nature immunology. 2005;6(12):1245-52.
8. Rodriguez‐Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunological reviews. 2009;229(1):259-70.
9. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415(6871):536-41.
10. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nature immunology. 2003;4(11):1102-10.
11. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. Journal of Experimental Medicine. 2006;203(6):1413-8.
12. Seki M, Oomizu S, Sakata K-m, Sakata A, Arikawa T, Watanabe K, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clinical immunology. 2008;127(1):78-88.
13. Du WT, Zhao HF, Xu JH, Gu DS, Xue F, Ge J, et al. The role of T-cell immunoglobulin-and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Human immunology. 2009;70(6):398-402.
14. Chae S-C, Park Y-R, Shim S-C, Yoon K-S, Chung H-T. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunology letters. 2004;95(1):91-5.
15. Tang F, Wang F, An L, Wang X. Upregulation of Tim-3 on CD4+ T cells is associated with Th1/Th2 imbalance in patients with allergic asthma. International journal of clinical and experimental medicine. 2015;8(3):3809.
16. Barlow J, Wong S, Ballantyne S, Jolin H, McKenzie A. Tim1 and Tim3 are not essential for experimental allergic asthma. Clinical & Experimental Allergy. 2011;41(7):1012-21.
17. Singh AK, Stock P, Akbari O. Role of PD‐L1 and PD‐L2 in allergic diseases and asthma. Allergy. 2011;66(2):155-62.
18. McGee HS, Yagita H, Shao Z, Agrawal DK. Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma. American journal of respiratory cell and molecular biology. 2010;43(4):432-42.
19. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T, et al. Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses. European journal of immunology. 2003;33(10):2773-82.
20. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clinical and Experimental Allergy. 2000;30(6; SUPP/1):2-5.
21. Hiraishi Y, Nambu A, Shibui A, Nakanishi W, Yamaguchi S, Morita H, et al. TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens. Allergology International. 2016;65(4):459-65.
22. Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. The Journal of clinical investigation. 2014;124(11):4678.
23. Kearley J, McMillan SJ, Lloyd CM. Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti–Tim-3 antibody in vivo. Journal of Experimental Medicine. 2007;204(6):1289-94.
24. Bratke K, Fritz L, Nokodian F, Geißler K, Garbe K, Lommatzsch M, et al. Differential regulation of PD‐1 and its ligands in allergic asthma. Clinical & Experimental Allergy. 2017;47(11):1417-25.
25. Deppong C, Juehne TI, Hurchla M, Friend LD, Shah DD, Rose CM, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. The Journal of Immunology. 2006;176(7):3909-13.
26. Wang S, Zhu X, Xu Y, Zhang D, Li Y, Tao Y, et al. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal–fetal interface. Human Reproduction. 2016;31(4):700-11.
27. Li Z, Ju Z, Frieri M. The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity. Allergy and asthma proceedings. 2013;34(1):e21-6. Epub 2013/02/15.
28. Cai XZ, Huang WY, Qiao Y, Chen Y, Du SY, Chen D, et al. Downregulation of TIM-3 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2015;48(1):77-82. Epub 2014/12/11.
29. Li S, Peng D, He Y, Zhang H, Sun H, Shan S, et al. Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2014;122(10):899-904. Epub 2014/04/03.
30. Behar BNaSM. Regulation of neutrophils by interferon-γ limitslung inflammation during tuberculosis infection
J Exp Med 2011; 208(11):2251-62.
| Files | ||
| Issue | Vol 17, No 6 (2018) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijaai.v17i6.614 | |
| Keywords | ||
| Asthma Interferon-γ Interleukin-4 PD-1 Tim-3 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
